Cizzle Biotechnology Holdings Plc (LON:CIZ)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 1.150
0.00 (0.00%)
Nov 5, 2026, 3:15 PM GMT
LON:CIZ Market Cap
LON:CIZ has a market cap or net worth of 4.89 million as of November 5, 2026. It is the 43,724th most valuable company in the world and the 985th biggest in the United Kingdom. Its market cap has decreased by 25.28% in one year.
Market Cap
4.89M
Enterprise Value
4.81M
Revenue
n/a
Global Rank
Country Rank
#985 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since May 14, 2021, LON:CIZ's market cap has decreased from 23.76M to 4.89M, a decrease of -79.43%. That is a compound annual growth rate of -25.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 4.89M | -20.46% |
| Dec 31, 2025 | 6.14M | - |
| Dec 31, 2024 | 6.14M | -13.40% |
| Dec 29, 2023 | 7.09M | 40.94% |
| Dec 30, 2022 | 5.03M | -33.79% |
| Dec 31, 2021 | 7.60M | -68.00% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thalia Therapeutics | 9.78M |
| Aptamer Group | 9.37M |
| Palatin Technologies | 7.26M |
| Fusion Antibodies | 7.26M |
| CRISM Therapeutics | 6.73M |
| Solvonis Therapeutics | 6.30M |
| OptiBiotix Health | 5.68M |
| Theracryf | 4.70M |